Published in Can J Cardiol on October 01, 2009
The aging Canadian population and hospitalizations for acute myocardial infarction: projection to 2020. BMC Cardiovasc Disord (2012) 0.79
Early discharge after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care (2013) 0.77
Root causes for delayed hospital discharge in patients with ST-segment Myocardial Infarction (STEMI): a qualitative analysis. BMC Cardiovasc Disord (2015) 0.75
NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge. Neth Heart J (2016) 0.75
Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost. Vasc Health Risk Manag (2017) 0.75
Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med (2003) 7.25
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation (2000) 5.15
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med (2000) 4.19
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
Time to treatment in primary percutaneous coronary intervention. N Engl J Med (2007) 3.95
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol (2005) 1.52
A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med (1988) 1.39
Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation (2004) 1.33
Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol (2004) 1.27
Restricted weekend service inappropriately delays discharge after acute myocardial infarction. Heart (2002) 1.02
Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making. Eur Heart J (2003) 0.82
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet (2011) 8.49
Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med (2010) 6.05
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA (2006) 5.74
Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med (2006) 5.24
Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol (2010) 5.09
Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med (2009) 4.83
Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease. J Am Coll Cardiol (2012) 3.45
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA (2007) 3.09
Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation (2007) 2.59
Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol (2009) 2.23
Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Ann Intern Med (2007) 2.14
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet (2003) 2.10
Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation (2009) 1.99
Radial artery access as a predictor of increased radiation exposure during a diagnostic cardiac catheterization procedure. JACC Cardiovasc Interv (2011) 1.78
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Coll Cardiol (2007) 1.75
The risks of waiting for cardiac catheterization: a prospective study. CMAJ (2002) 1.70
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. Eur Heart J (2008) 1.65
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. Am Heart J (2009) 1.47
Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure. Eur Heart J (2003) 1.44
Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv (2010) 1.43
A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions. Am Heart J (2006) 1.41
Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions. J Invasive Cardiol (2005) 1.40
Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigators. Circ Cardiovasc Qual Outcomes (2012) 1.24
Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol (2012) 1.22
Radial artery versus femoral artery access options in coronary angiogram procedures: randomized controlled trial of a patient-decision aid. Circ Cardiovasc Qual Outcomes (2012) 1.13
Determinants of variations in coronary revascularization practices. CMAJ (2011) 1.08
Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial. JACC Cardiovasc Interv (2013) 1.06
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J (2009) 1.02
Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure. J Card Fail (2006) 0.99
Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction--the RADIAL-AMI pilot randomized trial. Am Heart J (2005) 0.96
Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure. PLoS One (2010) 0.95
Radiation dose in interventional cardiology procedures: urgent need for monitoring dose and establishing diagnostic reference levels. Healthc Q (2008) 0.93
The relationship of body mass index to outcomes after percutaneous coronary intervention. J Interv Cardiol (2006) 0.93
Optimal method of coronary revascularization in patients receiving dialysis: systematic review. Clin J Am Soc Nephrol (2009) 0.90
Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromes. EuroIntervention (2011) 0.90
Predictors of increased radiation dose during percutaneous coronary intervention. Am J Cardiol (2009) 0.88
Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting. Eur Heart J (2004) 0.86
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both. Am J Cardiol (2005) 0.86
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. Am Heart J (2009) 0.85
Incremental value of left ventricular systolic and diastolic function to determine outcome in patients with acute ST-segment elevation myocardial infarction: the echocardiographic substudy of the OASIS-6 trial. Echocardiography (2014) 0.84
A national survey of Canadian practice patterns of warfarin after anterior wall myocardial infarction in the current era of dual antiplatelet therapy. Am J Cardiol (2010) 0.83
Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv (2012) 0.83
A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting. Can J Cardiol (2004) 0.83
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. J Am Coll Cardiol (2009) 0.83
Insight into capacity planning for cardiac catheterization services: policy lessons learned from "Looking in the Mirror" over a decade. Health Policy (2009) 0.82
An even smaller area variation: differing practice patterns among interventional cardiologists within a single high volume tertiary cardiac centre. Health Policy (2010) 0.82
Impact of clinical urgency, physician supply and procedural capacity on regional variations in wait times for coronary angiography. BMC Health Serv Res (2010) 0.82
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial. J Thromb Thrombolysis (2010) 0.82
Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials. Eur Heart J (2009) 0.81
Predictors of normal coronary arteries at coronary angiography. Am Heart J (2013) 0.81
Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction. J Thromb Thrombolysis (2010) 0.80
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker. Ther Adv Cardiovasc Dis (2009) 0.80
Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): protocol for a pragmatic, cluster-randomized controlled trial. Implement Sci (2012) 0.80
Canadian Cardiovascular Society position statement on radiation exposure from cardiac imaging and interventional procedures. Can J Cardiol (2013) 0.80
Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure. Eur J Heart Fail (2008) 0.80
Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience. Can J Cardiol (2010) 0.79
Comparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice. Can J Cardiol (2008) 0.79
Primary and rescue percutaneous coronary intervention with paclitaxel-eluting stent implantation in ST-elevation myocardial infarction. Am J Cardiol (2006) 0.78
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. Eur Heart J (2008) 0.78
An international survey of clinical practice during primary percutaneous coronary intervention for ST-elevation myocardial infarction with a focus on aspiration thrombectomy. EuroIntervention (2013) 0.78
Improving the timeliness of care for patients with acute ST-elevation myocardial infarction: implications of "self-transport" versus use of EMS. Healthc Q (2010) 0.77
Treatment assignment of high-risk symptomatic severe aortic stenosis patients referred for transcatheter AorticValve implantation. Am J Cardiol (2013) 0.77
The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study. Nat Clin Pract Cardiovasc Med (2008) 0.76
Radiation exposure from medical imaging: a silent harm? CMAJ (2011) 0.75
ST-elevation myocardial infarction: is there time for Q waves? CMAJ (2012) 0.75
Reperfusion for STEMI in current Canadian practice: Are we closing the care gap? Mcgill J Med (2011) 0.75
Low rates of angiographic and clinical restenosis with the new flexible MedStent for the treatment of single discrete coronary lesions. J Interv Cardiol (2004) 0.75
Prevalence of bruising at the vascular access site one week after elective cardiac catheterisation or percutaneous coronary intervention. J Clin Nurs (2011) 0.75
The effects of exercise training on insulin resistance in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil (2007) 0.75
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment. Eur Heart J (2007) 0.75